BENLYSTA is the first medicine approved to treat systemic lupus and adults with active lupus nephritis, an important treatment advance for patients with this incurable ... Dec 18
Abbott has launched its clip delivery system, a minimally invasive heart valve repair device to treat mitral regurgitation in India. ... Dec 18
ACTIV-3 is an NIH-led public-private partnership designed to accelerate the development of the most promising treatments and vaccine candidates for COVID-19.... Dec 18
... Dec 18
Rivaroxaban is currently sold by Bayer under the brand name of Xarelto, in the Indian market.... Dec 18
Tanzania will be the first country in Africa that will benefit from this collaboration between Biocon Biologics and CSSC.... Dec 17
Patients with newly diagnosed esophageal and GEJ cancer face an aggressive disease with a poor prognosis, despite the currently available treatment options... Dec 17
... Dec 16
CIPtest is a reliable high-performing kit that has been validated and approved by ICMR.... Dec 16
This new dosing option is consistent with the approved Imfinzi dosing in extensive-stage small cell lung cancer and once approved, will be available to ... Dec 15
Sanofi renewed a partnership agreement with the WHO, consolidating a 20-year collaboration to fight some of the most Neglected Tropical Diseases... Dec 15
COPD is a progressive disease, which can cause obstruction of airflow in the lungs resulting in debilitating bouts of breathlessness and is the third leading ... Dec 14
The impact of the disease is significant, with breast cancer responsible for more than 137,000 deaths per year.... Dec 14
Biocon subsidiary Mylan advances their ... Dec 14
Asenapine is an atypical antipsychotic indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults.... Dec 11
Bristol Myers Squibb today announced that its wholly-owned subsidiary, Celgene, and Cipla have settled their litigation related to patents for REVLIMID.... Dec 11
Fostemsavir addresses a critical unmet need in HIV care for those with little to no treatment options left.... Dec 11
... Dec 11
If approved, Inrebic will become the first new therapy for myelofibrosis in Europe in nearly a decade.... Dec 11
Enhertu continued to demonstrate impressive efficacy and durable responses in patients with HER2-positive metastatic breast cancer following two or more prior HER2-based regimens.... Dec 10
AstraZeneca has agreed to sell the rights to Crestor and associated medicines in over 30 countries in Europe, except the UK and Spain.... Dec 01
... Dec 01
According to IQVIA sales data for the 12 month period ending October 2020, the Inlyta Tablets market achieved annual sales of approximately $518.8 million*.... Dec 01
-Advertisements-
.jpeg)
Sunday, April 06, 2025
.jpeg)
.jpeg)
.jpeg)
.jpeg)
